Liz Roper, PhD
Chair and Co-Founder
Dr. Roper joined Epidarex Capital as a Partner in 2013. She has more than 19 years of experience in the Life Science and Healthcare industry, either as a venture investor or an operating executive. She has led a number of venture capital investments in early stage biotech companies, and has held senior operational roles, from Chair of Board to senior management positions, focused on shaping and building early stage life science opportunities into successful companies and investments. Prior to joining Epidarex, Dr. Roper was Head of Business Development and part of the management team at Chroma Therapeutics Ltd., an Oxford-based venture-backed drug discovery and development company focused on inflammatory disorders and oncology. Dr. Roper led the establishment of several major company-building alliances including a multi‐target deal with GlaxoSmithKline around Chroma’s novel platform. She is a former executive with the Life Science venture capital team at the Investments Division of The Wellcome Trust. She is also a former member of the Life Science team at Atlas Ventures, London. Dr. Roper currently Chairs the Boards of Adorx Ltd and Epidarex Exeed Ltd and serves on the Board of Directors of Nodthera Ltd., Mironid Ltd., Caldan Therapeutics Ltd. and EM Imaging Ltd. Dr. Roper holds a B.Sc. (Hons) in Biochemistry (1st class) from the University College Cork, and a Ph.D. from the Imperial Cancer Research Fund.